Font size:
Print
Patient-driven discovery reveals potential target for autoimmune diseases
Context: Researchers at Yale School of Medicine discovered mutations causing a deficiency in phosphatidylinositol 3-kinase-gamma (PI3Kγ), a crucial signalling molecule in immune cells.
Research Findings & Significance:
- Role of PI3Kγ in Immune Response: The team discovered that PI3Kγ is essential for activated B cells to differentiate into antibody-secreting cells.
- Implications for Autoimmune Diseases: Therapeutically blocking PI3Kγ might treat the overproduction of antibodies in autoimmune diseases.
-
- Potential for Broader Impact: Beyond the rare cases of PI3Kγ deficiency, these findings could help develop new interventions for autoimmune diseases.
- “These sorts of monogenic, single-gene defect diseases help us learn fundamental biology directly from patients
- Impact of PI3Kγ Deficiency:
-
- Focus: The lab studies rare immune disorders caused by single gene mutations to understand human immunology.
- Immune Defects: The mutation led to immune-mediated damage in the patient’s gut and lungs and reduced antibody levels.
How do B cells become antibody-producing cells?
- Antibodies are key components of the adaptive immune system, targeting foreign invaders such as bacteria or viruses.
- B cells are crucial for antibody production and immune memory.
- B cells activate when an antigen binds to their receptors and form germinal centres. Germinal centres help B cells become optimal antibody producers and decide their fate.
- B cells can become memory cells or antibody-secreting cells (ASCs).
- Memory cells “remember” antigens for rapid immune responses upon re-exposure.
- ASCs release large amounts of antibodies into the blood to target the intruder.
PI3Kγ plays essential role in B cell differentiation:
- 2019 Experiment: Knockout and control lab mice were exposed to pet store mice, revealing that PI3Kγ is critical for antibody production in mice, similar to humans.
- Latest Research: The team created mouse models with PI3Kγ knocked out in specific immune cells (B cells, T cells, macrophages, dendritic cells) to determine which cells require PI3Kγ.
- Findings: Removing PI3Kγ from B cells caused significant reductions in antibody response, indicating its necessity for proper B cell function.
- PI3Kγ was found to be crucial for B cell differentiation into antibody-secreting cells (ASCs), but not for B cell activation or germinal centre formation.
PI3K inhibitors could potentially treat autoimmune diseases
- Team identified PI3Kγ as crucial for B cell differentiation and a potential target for treating autoimmune diseases.
- Current autoimmune treatments often wipe out B cells, increasing infection risk, if PI3K inhibitors, used for cancers and rare diseases, could regulate an overactive immune system.
- By using human tonsil organoid models, PI3Kγ-targeting drugs blocked B cells’ ability to differentiate into antibody-secreting cells (ASCs).
- Future studies will test PI3K inhibitors in pre-clinical autoimmunity mouse models.